GlassScriptPhysician profile
Miguel Macaoay
NPI 1770673048
$1,859.00
in general payments reported to CMS, 2019-2025
16 companies · $545 in 2025
The $545 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.24 · 2020: $27.54 · 2023: $430 · 2024: $800 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,775.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $414.53 | 2023-2025 | Qelbree, Qelbree |
| Neurocrine Biosciences, INC. | $335.58 | 2019-2025 | Ingrezza |
| Abbvie INC. | $310.68 | 2023-2025 | |
| Tris Pharma INC | $144.25 | 2023-2025 | Dyanavel Xr, Onyda Xr |
| Corium, LLC | $119.16 | 2023-2025 | Azstarys |
| Otsuka America Pharmaceutical, INC. | $92.44 | 2023-2024 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Vanda Pharmaceuticals INC. | $87.14 | 2024-2025 | Fanapt, Hetlioz |
| Teva Pharmaceuticals USA, INC. | $83.46 | 2024-2025 | Austedo Xr, Austedo Xr |
| Alkermes, INC. | $80.16 | 2023-2024 | Aristada, Lybalvi |
| Lundbeck LLC | $60.65 | 2023-2024 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Ironshore Pharmaceuticals INC. | $48.97 | 2024 | |
| Axsome Therapeutics, INC. | $20.62 | 2025 | Auvelity |
| Neuronetics, INC. | $17.90 | 2019 | |
| Sanofi Pasteur INC. | $17.06 | 2025 | |
| Adlon Therapeutics L.P. | $13.34 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $13.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miguel Macaoay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.